Lenalidomide (Revlimid®) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis

✍ Scribed by Arie Neymotin; Susanne Petri; Noel Y. Calingasan; Elizabeth Wille; Peter Schafer; Charles Stewart; Kenneth Hensley; M. Flint Beal; Mahmoud Kiaei

• Book ID: 118441257
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 668 KB
• Volume: 220
• Category: Article
• ISSN: 0014-4886
• DOI: 10.1016/j.expneurol.2009.08.028